Cargando…
Bv8 Blockade Sensitizes Anti-PD1 Therapy Resistant Tumors
Myeloid-derived suppressor cells (MDSCs) are known to promote tumor growth in part by their immunosuppressive activities and their angiogenesis support. It has been shown that Bv8 blockade inhibits the recruitment of MDSCs to tumors, thereby delaying tumor relapse associated with resistance to antia...
Autores principales: | Benguigui, Madeleine, Vorontsova, Avital, Timaner, Michael, Levin, Sapir, Haj-Shomaly, Jozafina, Deo, Abhilash, Menachem, Rotem, Manobla, Bar, Cooper, Tim J., Raviv, Ziv, Shaked, Yuval |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301046/ https://www.ncbi.nlm.nih.gov/pubmed/35874722 http://dx.doi.org/10.3389/fimmu.2022.903591 |
Ejemplares similares
-
Chemotherapy-induced tumor immunogenicity is mediated in part by megakaryocyte-erythroid progenitors
por: Vorontsova, Avital, et al.
Publicado: (2023) -
T Cells Promote Metastasis by Regulating Extracellular Matrix Remodeling following Chemotherapy
por: Haj-Shomaly, Jozafina, et al.
Publicado: (2022) -
Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach
por: Benguigui, Madeleine, et al.
Publicado: (2017) -
The Dichotomous Role of Bone Marrow Derived Cells in the Chemotherapy-Treated Tumor Microenvironment
por: Vorontsova, Avital, et al.
Publicado: (2020) -
Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells
por: Benguigui, Madeleine, et al.
Publicado: (2019)